Samantha Pearce, SVP, Head of Europe & Internat at Jazz Pharmaceuticals plc (JAZZ), sold 1,062 shares at $159.59 ($169K) on 2023-01-03, disclosed to the SEC on 2023-01-05.
Open-market sale of $169k JAZZ by SVP, Head of Europe & Internat. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $159.59 | 531 | $85K | 50.0% |
| 2 | $159.59 | 531 | $85K | 50.0% |
| Total | $159.59 avg | 1,062 | $169K | 100% |
| Filing → |
| JAZZ | SELL | 2022-12-15 | $165K | — | Filing → |
| JAZZ | SELL | 2022-11-14 | $165K | — | Filing → |
| JAZZ | SELL | 2022-09-07 | $167K | — | Filing → |